Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
Atelier "Atelier pratique : Apprenez 脿 cr茅er vos propres vid茅os de vulgarisation scientifique et de protocole"
Cet atelier sera pr茅sent茅 en anglais./neuroCategory:聽MNI
Montreal, March 26, 2025 鈥� 黑料社鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based...
Neuroscientist Alan Evans and music performance scholar Michael McMahon among 黑料社 community members recognized for exceptional accomplishments and service聽...
Join us on聽May 7th聽at noon for the next 黑料社 Cares webcast to support informal caregivers. During candid, interviews with leading experts, Claire Webster explores topics related to caring for a...
D2R | DNA to RNA is launching the International Partnerships Program (IPP) to strengthen large-scale, multi-institutional collaborations with leading global organizations. This strategic funding...
RSS